TY - JOUR
T1 - VIP neurotrophism in the central nervous system
T2 - Multiple effecters and identification of a femtomolar-acting neuroprotective peptide
AU - Brenneman, Douglas E.
AU - Glazner, Gordon
AU - Hill, Joanna M.
AU - Hauser, Janet
AU - Davidson, Ariane
AU - Gozes, Illana
PY - 1998
Y1 - 1998
N2 - Vasoactive intestinal peptide has neurotrophic and growth-regulating properties. As in the case of many neurotrophic molecules, VIP also has neuroprotective properties, including the prevention of cell death associated with excitotoxicity (NMDA), beta amyloid peptide, and gp120, the neurotoxic envelope protein from the human immunodeficiency virus. The neurotrophic and neuroprotective properties are mediated in part through the action of glial-derived substances released by VIP. These substance include cytokines, protease nexin I, and ADNF, a novel neuroprotective protein with structural similarities to heat-shock protein 60. Antiserum against ADNF produced neuronal cell death and an increase in apoptotic neurons in cell culture. A 14 amino acid peptide (ADNF-14) derived from ADNF has been discovered that mimics the survival-promoting action of the parent protein. These studies support the conclusion that VIP, PACAP, and associated molecules are both important regulators of neurodevelopment and strong candidates for therapeutic development for the treatment of neurodegenerative disease.
AB - Vasoactive intestinal peptide has neurotrophic and growth-regulating properties. As in the case of many neurotrophic molecules, VIP also has neuroprotective properties, including the prevention of cell death associated with excitotoxicity (NMDA), beta amyloid peptide, and gp120, the neurotoxic envelope protein from the human immunodeficiency virus. The neurotrophic and neuroprotective properties are mediated in part through the action of glial-derived substances released by VIP. These substance include cytokines, protease nexin I, and ADNF, a novel neuroprotective protein with structural similarities to heat-shock protein 60. Antiserum against ADNF produced neuronal cell death and an increase in apoptotic neurons in cell culture. A 14 amino acid peptide (ADNF-14) derived from ADNF has been discovered that mimics the survival-promoting action of the parent protein. These studies support the conclusion that VIP, PACAP, and associated molecules are both important regulators of neurodevelopment and strong candidates for therapeutic development for the treatment of neurodegenerative disease.
UR - http://www.scopus.com/inward/record.url?scp=0032430335&partnerID=8YFLogxK
U2 - 10.1111/j.1749-6632.1998.tb11180.x
DO - 10.1111/j.1749-6632.1998.tb11180.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 9928014
AN - SCOPUS:0032430335
SN - 0077-8923
VL - 865
SP - 207
EP - 212
JO - Annals of the New York Academy of Sciences
JF - Annals of the New York Academy of Sciences
ER -
